{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:48:22Z","timestamp":1766065702187},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1053\/j.jrn.2006.04.006","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T10:55:42Z","timestamp":1152183342000},"page":"248-252","source":"Crossref","is-referenced-by-count":13,"title":["Novel Dosage Forms and Regimens for Sevelamer-Based Phosphate Binders"],"prefix":"10.1053","volume":"16","author":[{"given":"Ajay","family":"Duggal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Zhorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafif","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Plone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2006.04.006_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel)","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.04.006_bib2","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ndt\/13.9.2303","article-title":"Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients","volume":"13","author":"Goldberg","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.04.006_bib3","first-page":"18","article-title":"A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients","volume":"51","author":"Chertow","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2006.04.006_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.04.006_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.04.006_bib6","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium \u00d7 phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.04.006_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2006.04.006_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.04.006_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in haemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.04.006_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000072822","article-title":"The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients","volume":"23","author":"Chertow","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2006.04.006_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.04.006_bib12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.04.006_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.04.006_bib14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.04.006_bib15","first-page":"238","article-title":"Phosphate binders, K\/DOQI Guidelines, and compliance","volume":"33","author":"Tomasello","year":"2004","journal-title":"Dial Transplant"},{"key":"10.1053\/j.jrn.2006.04.006_bib16","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/ajhp\/52.17.1895","article-title":"Medication knowledge and compliance among patients receiving long-term dialysis","volume":"52","author":"Cleary","year":"1995","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.jrn.2006.04.006_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1053\/j.jrn.2006.04.006_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003088-200241070-00005","article-title":"Sevelamer, a phosphate-binding polymer, is a non-absorbed compound","volume":"41","author":"Plone","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 5","key":"10.1053\/j.jrn.2006.04.006_bib19","first-page":"v93","article-title":"A randomized, cross-over study to compare once a day with three times per day sevelamer dosing","volume":"20","author":"Fischer","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227606000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227606000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T17:21:58Z","timestamp":1555694518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227606000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1051227606000872"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2006.04.006","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}